Imnovid

Medicinal product

(Invented) name

Imnovid

Active substance (s)

Pomalidomidas

Strength

4 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX06, Pomalidomide

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2013-08-05

Date of renewal

Documents

Imnovid informacija pacientams.pdf

Imnovid paciento kortele.pdf

Imnovid informacija specialistams.pdf

Imnovid informuotumo apie rizika forma.pdf

Imnovid nestumo stebejimo forma.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Hard capsules	1 vnt.
Pomalidomidas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
57048	71160	1071160	lizdinė plokštelė	N21		Receptinis	EU/1/13/850/004	Tiekiama	2024-12-31	-	No	-	-
101942	88044	1088044	lizdinė plokštelė	N14		Receptinis	EU/1/13/850/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2013-08-05	Registruotas